Detail akcie Avinger Rg online

Business Summary: Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Financial Summary: BRIEF: For the six months ended 30 June 2024, Avinger Inc revenues decreased 6% to $3.7M. Net loss applicable to common stockholders decreased 26% to $8.3M. Revenues reflect United States segment decrease of 5% to $3.4M, Germany segment decrease of 18% to $259K. Basic Earnings per Share excluding Extraordinary Items increased from -$19.55 to -$5.30.